Target intelligence / Profile preview

Reactive oxygen species and pro-oxidant systems (ROS)

Target
ROS
Molecular classification
Reactive molecules, Enzyme, Free radicals
01

Overview

Reactive oxygen species (ROS) and pro-oxidant systems represent a broad category of highly reactive oxygen-containing molecules and the enzymatic pathways that generate them, such as NADPH oxidases (NOX), xanthine oxidase, and the mitochondrial respiratory chain. Under physiological conditions, ROS act as critical secondary messengers in signal transduction and are essential for the immune system's ability to neutralize pathogens through the oxidative burst. However, an imbalance where ROS production exceeds the capacity of antioxidant defense mechanisms leads to oxidative stress, resulting in oxidative damage to DNA, lipids, and proteins. This damage is a central driver in the progression of various pathologies, including atherosclerosis, Parkinson's disease, and various cancers. Therapeutic interventions aim to mitigate this damage either by using antioxidant scavengers to neutralize existing radicals or by inhibiting the specific pro-oxidant enzymes responsible for their overproduction. Because ROS are involved in both vital signaling and pathological damage, therapeutic targeting requires precision to avoid interfering with necessary cellular functions.

Other names
Reactive oxygen speciesFree radicalsOxidantsReactive nitrogen speciesPro-oxidantsOxidative stress mediators
02

Mechanism of action

Drugs targeting these systems typically act by directly scavenging free radicals, inhibiting ROS-generating enzymes such as NADPH oxidase or xanthine oxidase, or inducing endogenous antioxidant enzymes through pathways like Nrf2 activation.

03

Biological functions

Cell signalingImmune responseApoptosisRedox homeostasisPathogen defense
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationDiabetes mellitusAging
05

Safety considerations

Disruption of essential physiological signalingImpairment of immune-mediated pathogen killingAntioxidant paradox (potential for increased mortality with high-dose supplementation)Off-target effects of enzyme inhibitors
06

Interacting drugs

N-acetylcysteine

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-Oxo-2-deoxyguanosine (8-OHdG)Protein carbonylsGlutathione (GSH/GSSG) ratioIsoprostanes

Beyond the preview

Go deeper on Reactive oxygen species and pro-oxidant systems (ROS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and pro-oxidant systems (ROS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call